Trial site
Seattle Neuropsychiatric Treatment Center
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Depression6 trials
- ALS (motor neurone disease)1 trial
- Idiopathic pulmonary fibrosis1 trial
- Multiple sclerosis1 trial
- Parkinson disease1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Active, not recruiting3 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Definium Therapeutics US, Inc.2 trials
- COMPASS Pathways1 trial
- Cybin IRL Limited1 trial
- Kernel1 trial
- LivaNova1 trial
- and 2 more
Running trials
Recruiting
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Recruiting
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Active, not recruiting
A Phase 3 Trial of DT120 for Generalized Anxiety Disorder (Voyage)
Enrolling by invitation
Prediction of REsponse to Depression Interventions Using Clinical and TD-fNIRS Measurements
Active, not recruiting
Active, not recruiting
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Depression4 recruiting
- ALS (motor neurone disease)1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Multiple sclerosis1 recruiting
- Parkinson disease1 recruiting
Site data: ClinicalTrials.govUpdated 15 Nov 2026